Skip to main content

Table 2 Follow-up schedule

From: Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial

 

V0

Cath

PCI

CABG

PTA

V1

V2

V3

V4

V5

V6

V7

V8

Time elapse from PTA

    

0

30 (±7)D

24 (±2)W

48 (±2)W

72 (±2)W

96 (±2)W

120 (±2)W

144 (±2)W

168 (±2)W

CRF

001

002

003

004

005

006

007

008

009

010

011

012

013

Markers/SNPs/miRNAs

    

X

        

CBC

X

            

BCS

X

            

BW/BH

X

            

BP/HR

X

    

X

X

X

X

X

X

X

X

History and PE

X

    

X

X

X

X

X

X

X

X

  1. BCS biochemistry study, BH body height, BP blood pressure, BW body weight, CABG coronary artery bypass grafting, Cath coronary catheterization, CBC complete blood cell count, CRF case report form, D days, HR heart rate, miRNAs micro-ribonucleic acids, PCI percutaneous coronary intervention, PE physical examination, PTA percutaneous transluminal angioplasty, SNPs single-nucleotide polymorphisms, V visit, W weeks
Back to article page

Trials

ISSN: 1745-6215